Baudax Bio acquires biotechnology firm TeraImmune

Baudax Bio has acquired all outstanding equity interests of biotechnology firm TeraImmune in a stock-for-stock deal.

Jul 3, 2023 - 20:00

Baudax Bio acquires biotechnology firm TeraImmune

Baudax Bio has acquired all outstanding equity interests of biotechnology firm TeraImmune in a stock-for-stock deal.

Read the original article

Tags:

Previous Article

Camena bags $10m in funding from Mercia

Generative AI – beyond the hype

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Italfarmaco secures FDA approval for Duchenne muscular dystrophy drug

Italfarmaco secures FDA approval for Duchenne muscular ...

Mar 24, 2024

Suicides and homicides among young Americans jumped early in the pandemic, study says

Suicides and homicides among young Americans jumped ear...

Jun 16, 2023

Celltrion USA seeks FDA approval for CT-P47 biosimilar

Celltrion USA seeks FDA approval for CT-P47 biosimilar

Jan 29, 2024